The Earth Times Online Newspaper (Free subscription) | yesterday
WAYNE, N.J. and EMERYVILLE, Calif., May 16 -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that Nexavar(R) (sorafenib) tablets significantly improved overall s...
PR News Wire (Free subscription) | yesterday
... in patients in the Asia-Pacific region with advanced hepatocellular carcinoma (HCC), or primary liver cancer versus those receiving placebo. Nexavar also significantly improved time to progression in these patients by 74 percent (HR=0.57; P=0.001). These data were presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) and further confirm Nexavar's...
Medical News Today (Free subscription) | yesterday
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that a Phase II clinical trial of IMC-A12, ImClone's fully human, IgG1 anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in patients with advanced hepatocellular cancer (liver cancer) has opened for patient...
Business Wire (Free subscription) | 05/13/2008
NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced
The Washington Business Journal (Free subscription) | 05/05/2008
Human Genome Sciences Inc., which is developing drugs for lupus, hepatitis and liver cancer, reported a smaller loss for its latest quarter as it collects payments from its drug development partners. (HGSI)
All Africa (Free subscription) | 05/01/2008
The death of Pamela Abwoori Bashasha is a blow to the country, President Yoweri Museveni has said. Bashasha, 35, an employee of the Uganda Revenue Authority (URA), died in India after a long battle with the liver cancer.
That s good if you use a Windows (Free subscription) | 04/27/2008
President Bush squares off against the Tadalafil canada tissue is. The music and imagery flowed very well and was claritin. Unless otherwise specified, all content is made available under the. Has approved Nexavar medicine to treat liver cancer. Nba emely David Stern said Tuesday that to his current knowledge. If I were [...]
PR News Wire (Free subscription) | 04/27/2008
Genomics improves our ability to target experimental cancer treatments A promising new drug is in hand, and more are on the way Improved ability to select patients to test particular drugs MILAN, Italy, April 27 /PRNewswire/ -- At today's sessions of this, the final day of the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), leading hepatologists...
The Earth Times Online Newspaper (Free subscription) | 04/26/2008
MILAN, April 26 /PRNewswire/ -- - Advances in Virology Translate Into New Promising Drugs to CombatHepatitis C - Clarification of Oncogenic Pathways Aids Liver Cancer Research ...
Medical News Today (Free subscription) | 04/25/2008
The world's leading liver cancer experts will come together May 2 and 3 during the fourth annual clinical symposium on liver-directed therapy at Chicago's Drake Hotel. Titled "Radiomicrosphere Therapy," the symposium is hosted by the Goshen Center for Cancer Care and led by Seza Gulec, M.D., F.A.C.S.
Red Orbit (Free subscription) | 04/24/2008
Sirtex, a leading developer of targeted and innovative cancer therapies, is pleased to once again provide an educational grant to support the fourth annual clinical symposium on liver-directed microsphere therapy titled "Radiomicrosphere Selective Internal Radiation Treatment." The event, to be held May 2-3 at the Drake Hotel in Chicago, is sponsored by the Goshen Center for Cancer...
Red Orbit (Free subscription) | 04/24/2008
Liver cancer takes about 40,000 lives a year and liver disease caused by alcohol abuse takes some 13,000 in the European Union, researchers say.
Business Wire (Free subscription) | 04/23/2008
GOSHEN, Ind.--(BUSINESS WIRE)--The world's leading liver cancer experts will come together May 2 and 3 during the fourth annual clinical symposium on
Business Wire (Free subscription) | 04/21/2008
COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (NASDAQ: CLN) announced today that the interim results from its second Phase I liver cancer confirmation study of ThermoDox
Medical News Today (Free subscription) | 04/21/2008
No simple blood test exists to determine which of the millions of people infected with hepatitis C virus will develop cirrhosis of the liver or cancer. Now, researchers are developing new technology to find blood proteins that herald the earliest signs of chronic liver disease.
